Compare BN Agrochem with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.71
- The company has reported losses. Due to this company has reported negative ROCE
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Trading & Distributors
INR 2,200 Cr (Small Cap)
44.00
20
0.00%
0.18
4.45%
4.97
Total Returns (Price + Dividend) 
BN Agrochem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

BN Agrochem Ltd is Rated Strong Sell
BN Agrochem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
BN Agrochem Ltd Hits Intraday High with 7.02% Surge on 20 Mar 2026
BN Agrochem Ltd recorded a robust intraday performance today, surging 7.02% to touch its day’s high of Rs 234. This marks a significant rebound following two consecutive days of decline, with the stock opening sharply higher and maintaining this elevated level throughout trading.
Read full news article Announcements 
Announcement Under Regulation 30 Of SEBI (LODR)-Updates On Scheme Of Amalgamation
05-Mar-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements)Regulations 2015 please find attached an update on Scheme of Amalgamation filed by the Company.
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) 2015 please find attached herewith intimation of publication of financial results for the third quarter and nine months ended December 31 2025 in newspaper.
Results-Financial Results For December 31 2025
13-Feb-2026 | Source : BSEPursuant to Regulation 30 read with regulation 33 of SEBI (LODR) 2015 please find attached un-audited Standalone & Consolidated for the third quarter ended December 31 2025.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.0%)
Anubhav Agarwal (5.93%)
Global Focus Fund (18.34%)
3.25%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 125.44% vs 0.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -167.20% vs 900.79% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 599.34% vs -692.71% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 618.05% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,158.87% vs 211.71% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 4,122.99% vs 0.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 731.31% vs -745.95% in Mar 2024







